Humira Approved for Treatment of Juvenile Rheumatoid Arthritis
February 26, 2008 by MedHeadlines
Filed under Children's Health, Drugs, FDA, Rheumatoid Arthritis
Humira, a drug commonly given to adult patients to treat rheumatoid arthritis, has now been approved to treat similar ailments in juvenile patients. Abbott recently announced that they received approval from the U.S. Food and Drug Administration to market Humira (adalimumab) as treatment to reduce the symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older. Read more
Loading ...
